Cite
HARVARD Citation
Jakob, J. et al. (n.d.). Phase II study of gefitinib in patients with advanced salivary gland cancers. Head & neck. 37 (5), pp. 644-649. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jakob, J. et al. (n.d.). Phase II study of gefitinib in patients with advanced salivary gland cancers. Head & neck. 37 (5), pp. 644-649. [Online].